← All organizations

3E Therapeutics Corporation

For profit

Also known as: Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Feb 28, 2022

Defunct as of Oct 1, 2019

Timeline

2010s

Jun 1, 2013
3E Therapeutics Corporation— Founded
Oct 1, 2019
3E Therapeutics Corporation— Defunct

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

iodixanol

Phase 1 (1 own, 0 via acquisition)

ricolinostat

Indications

Studied for

Recent trials (3)

NCT05229042Lead sponsorPhase 1Feb 28, 2022
NCT05193851Lead sponsorPhase 1Jan 12, 2022
NCT02377895Lead sponsorPhase 1/Phase 2Mar 1, 2015

Details

Founded: La Jolla, CA, US Jun 1, 2013
Last known activity: Feb 28, 2022